UroGen Pharma | ApexOnco - Clinical Trials news and analysis

x

“The team is super responsive to my inquiries and suggestions”

Chief Business Officer

US public biotech company

Click here for more information

Data insights

28 May 2025

The month ahead: June’s upcoming events

Crunch time approaches for UroGen.

Data insights

29 January 2025

NextCure joins the B7-H4 brigade

Meanwhile, Olema’s KAT6 inhibitor will take on rival projects from Pfizer and Menarini.

Subscribe to UroGen Pharma